Scientists Name New Type of Memory Loss Often Mistaken For Alzheimer’s

A newly identified form of dementia, often confused with Alzheimer’s disease, has been named Limbic-predominant Amnestic Neurodegenerative Syndrome (LANS). This breakthrough in neurodegenerative research could significantly improve the diagnosis and treatment of patients with memory loss. LANS differs from Alzheimer’s in its progression and symptoms, particularly affecting individuals over the age of 80 with milder memory issues that advance more slowly than Alzheimer’s. Researchers have developed specific diagnostic criteria to distinguish LANS from Alzheimer’s, offering new hope for accurate diagnoses and better patient care.¹

Differentiating LANS from Alzheimer’s Disease

One of the most challenging aspects of diagnosing dementia has been distinguishing between Alzheimer’s disease and other neurodegenerative conditions. LANS presents with a distinct set of brain changes, primarily affecting the limbic system, which is crucial for memory and emotional regulation. Unlike Alzheimer’s, where tau protein tangles accumulate in areas related to spatial awareness, LANS is associated with degeneration in the hippocampus and other parts of the limbic system. This results in memory issues but spares other cognitive functions, making it critical for clinicians to correctly identify the syndrome.²

Read More: 19-year-old man is youngest ever patient to be diagnosed with Alzheimer’s

New Diagnostic Criteria

To aid in the differentiation of LANS from Alzheimer’s, researchers have established a set of clinical criteria. These include the gradual progression of memory loss over at least two years, onset after the age of 75, and specific patterns of brain atrophy observable through MRI scans. Notably, patients with LANS tend to retain better visuospatial abilities compared to those with Alzheimer’s. This new framework allows doctors to more accurately diagnose living patients, which was previously possible only through post-mortem examination.

The Role of TDP-43 Protein

A key feature of LANS is the presence of TDP-43, a protein that accumulates in the limbic system. This buildup is also characteristic of another condition known as Limbic-predominant Age-related TDP-43 Encephalopathy (LATE), which is highly associated with LANS. While closely related to LATE, LANS can encompass any neurodegenerative condition that primarily affects the limbic system, making the role of TDP-43 a critical factor in diagnosis and understanding the disease’s progression.³

Read More: The Cause of Alzheimer’s Could Be Coming From Inside Your Mouth, Study Claims

Implications for Treatment and Patient Care

The identification of LANS has significant implications for patient care, particularly in treatment planning. Since LANS progresses more slowly than Alzheimer’s, patients diagnosed with this condition may not experience the severe cognitive decline often associated with Alzheimer’s. This distinction allows for more tailored treatment options and counseling for patients and their families. It also opens the door to more targeted clinical trials that could lead to better therapeutic interventions.⁴

Future Research Directions

Ongoing research is essential to further refine the understanding of LANS and its relationship with other forms of dementia. Researchers are continuing to study the mechanisms underlying LANS, particularly the role of TDP-43 and other biomarkers. Future studies may explore potential treatments that could slow or halt the progression of LANS, offering new hope for patients who are often misdiagnosed with Alzheimer’s.

Conclusion

The identification and classification of LANS mark a significant advance in the field of neurodegenerative research. By distinguishing it from Alzheimer’s, medical professionals can provide more accurate diagnoses and better care for older adults experiencing memory loss. As research progresses, the understanding of LANS will continue to evolve, potentially leading to new treatments that improve the quality of life for those affected by this newly recognized syndrome.

Read More: Neuroscientists Warn of “Cascading” Alzheimer’s Risk From These Two Habits